These new drugs are enhancing cancer treatment by increasing specificity and reducing side effects. Targeted therapies, for instance, are designed to interfere with cancer cell growth at the molecular level, thereby improving efficacy and minimizing damage to healthy cells. Immunotherapies, including checkpoint inhibitors, have shown remarkable results in cancers such as melanoma and lung cancer, offering long-term remission for some patients. Furthermore, gene therapies are paving the way for personalized medicine, allowing for treatments tailored to the individual genetic profiles of patients.
